A new UK study by Octave seeks to understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions, including cancer. Funded by the Medical Research Council (MRC), researchers from the Universities of Glasgow, Birmingham (sponsors), Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust will contribute to this nationally collaborative […]